No shortcuts to SARS-CoV-2 antivirals
Science
.
2021 Jul 30;373(6554):488-489.
doi: 10.1126/science.abj9488.
Authors
Aled Edwards
1
2
,
Ingo V Hartung
1
2
Affiliations
1
Structural Genomics Consortium, 101 College Street, Toronto, Canada.
[email protected]
[email protected]
.
2
Merck Healthcare KGaA, Frankfurter Straße 250, Darmstadt, Germany.
[email protected]
[email protected]
.
PMID:
34326222
DOI:
10.1126/science.abj9488
No abstract available
Publication types
Comment
MeSH terms
Antiviral Agents* / pharmacology
Antiviral Agents* / therapeutic use
COVID-19*
Humans
SARS-CoV-2
Virus Replication / drug effects
Substances
Antiviral Agents